If this is your first visit, be sure to
check out the FAQ by clicking the
link above. You may have to register
before you can post: click the register link above to proceed. To start viewing messages,
select the forum that you want to visit from the selection below.
just upgraded price target again
Goodbodys upgrade from London 3/1/04
I especially like this part :
"Adjusting our model to incorporate the revised Antegren numbers, potential upside on pricing and as an aquisition target, we now conservatively value Elan at between $11,77 and $17,47. We believe that even at the upper level, the stock would not be seen as overpriced.
We therefore believe there is considerable headroom for the stock and retain our Buy recommendation with an increased price target of $17.00. This represents a 18% premium on the current price, which we consider undemanding given the potential upside to current numbers and the sector appetite for blockbuster drugs "
Comment